Lysophosphatidic acids and neuropathic pain intensity

Takeaway

  • Lysophosphatidic acid (LPA) levels in cerebrospinal fluid (CSF) correlate with pain intensity and symptoms in people with neuropathic pain.

Why this matters

  • LPA signalling pathways may present a novel target for therapeutic agents in neuropathic pain.